Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00793351
First received: November 17, 2008
Last updated: November 23, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)